The occurrence of human papillomavirus types in the formation of neoplastic transformation of the epithelium of the cervix in “lesser abnormalies”
- Authors: Sycheva E.G.1, Nazarova N.M.1, Burmenskaya O.V.1, Prilepskaya V.N.1, Trofimov D.Y.1
-
Affiliations:
- Kulakov National Medical Research Centre for Obstetrics, Gynaecology and Perinatology
- Issue: Vol 22, No 1 (2020)
- Pages: 19-22
- Section: ORIGINAL ARTICLE
- URL: https://ogarev-online.ru/2079-5831/article/view/33964
- DOI: https://doi.org/10.26442/20795696.2020.1.200015
- ID: 33964
Cite item
Full Text
Abstract
Aim. To assess the frequency of human papillomavirus (HPV) occurrence according to the IARC classification in patients with “lesser abnormalie” of cervical epithelial lesions and analyze their role in the formation of SIL.
Materials and methods. The study included 129 HPV-positive women aged 18–45 years (average age 34 to 11 years) with cytological conclusion NILM, ASCUS or LSIL. Patients are divided into 3 groups depending on the results of the cytological smear: 1 group (NILM/HPV) – 66 (51.2%), 2 group (ASCUS/HPV) – 28 (21.7%), 3 group (LSIL/HPV) – 35 (27.1%). During dynamic observation for 24 months. A comprehensive clinical-laboratory examination was carried out, including HPV-typing, cytological examination, extended colposcopy every 6 months, sighting biopsy of the cervix (according to the indications).
Results. According to the results of the pathomorphological study, squamous intraepithelial lesions neoplasia (cervical intraepithelial neoplasia – CIN+) was verified in 59 (71.9%) of the results of the study: LSIL (CIN I) – 53 (64.6%), HSIL (CIN II–III) – 6 (4.6%). The morphological diagnosis of LSIL (CIN I) was established in 1 group (NILM/HPV+) in 20 (55.6%), 2 groups (ASCUS/HPV+) – 9 (32%), 3 group (LSIL/HPV) – 24 (68.6%); HSIL (CIN II–III) in group 1 – 2 (5.6%), in 2 group – 3 (10.7%) and in the 3 group – 1 (2.9%).
Conclusions. In patients with “lesser abnormalies” of cervical lesions in the formation of CIN+ participated HPV group 1 – in 79.1%, groups 2A – in 5.5%, groups 2B – in 15.4% of cases. The HPV high carcinogenic risk (group 1) was involved in the formation of HSIL (CIN II–III). The neoplastic transformation of the cervical epithelium of the studied patients was caused by the persistence of HPV 16, 58, 39, 18, 51, 68, 56, 82, 35, 52, 53, 35 types.
Full Text
##article.viewOnOriginalSite##About the authors
Elena G. Sycheva
Kulakov National Medical Research Centre for Obstetrics, Gynaecology and Perinatology
Author for correspondence.
Email: el.bona@mail.ru
doctor
Russian Federation, MoscowNiso M. Nazarova
Kulakov National Medical Research Centre for Obstetrics, Gynaecology and Perinatology
Email: grab2@yandex.ru
ORCID iD: 0000-0001-9499-7654
D. Sci. (Med.)
Russian Federation, MoscowOlga V. Burmenskaya
Kulakov National Medical Research Centre for Obstetrics, Gynaecology and Perinatology
Email: bourmenska@mail.ru
D. Sci. (Biol.)
Russian Federation, MoscowVera N. Prilepskaya
Kulakov National Medical Research Centre for Obstetrics, Gynaecology and Perinatology
Email: VPrilepskaya@mail.ru
ORCID iD: 0000-0002-7643-8346
D. Sci. (Med.)
Russian Federation, MoscowDmitry Yu. Trofimov
Kulakov National Medical Research Centre for Obstetrics, Gynaecology and Perinatology
Email: d.trofimov@dna-tech.ru
ORCID iD: 0000-0002-1569-8486
D. Sci. (Biol.), Prof. RAS
Russian Federation, MoscowReferences
- Bray F, Ferlay J, Soerjomataram I et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68 (6): 394–424.
- Massad LS, Einstein MH, Huh WK et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer prcursors. Obstet Gynecol 2013; 121 (4): 829–46.
- Fujiwara H, Suzuki M, Morisawa H et al. The Impact of Triage for Atypical Squamous Cells of Undetermined Significance with Human Papillomavirus Testing in Cervical Cancer Screening in Japan. Asian Pac J Cancer Prev 2019; 20 (1): 81–5.
- Kang WD, Ju UC, Kim SM. Is human papillomavirus genotype important in predicting disease progression in women with biopsy-proven negative or CIN1 of atypical squamous cell of undetermined significance (ASC-US) cytology? Gynecol Oncol 2018; 148 (2): 305–10.
- Сычева Е.Г., Назарова Н.М., Бурменская О.В. и др. Персистенция ВПЧ высокого онкогенного риска и другие молекулярно-генетические предикторы развития цервикальных интраэпителиальных неоплазий. Акушерство и гинекология. 2018; 12: 104–10. [Sycheva E.G., Nazarova N.M., Burmenskaya O.V. et al. High-risk human papillomavirus persistence and other molecular genetic predictors for cervical intraepithelial neoplasias. Obstetrics and Gynecology. 2018; 12: 104–10 (in Russian).]
- De Villiers EM. Cross-roads in the classification of papillomaviruses. Virology 2013; 445 (1–2): 2–10.
- Burd EM. Human Papillomavirus Laboratory Testing: the Changing Paradigm. Clin Microbiol Rev 2016; 29 (2): 291–319.
- Saslow D, Solomon D, Lawson HW et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. ACS-ASCCP-ASCP Cervical Cancer Guideline Committee. CA Cancer J Clin 2012; 62: 147–72.
- Guan P, Howell-Jones R, Li N et al. Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer. Int J Cancer 2012; 131 (10): 2349–59.
- Halec G, Alemany L, Lloveras B et al. Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer. J Pathol 2014; 234 (4): 441–51.
- Arbyn M, Tommasino M, Depuydt C, Dillner J. Are 20 human papillomavirus types causing cervical cancer? J Pathol 2014; 234 (4): 431–5.
- Wang J, Tang D, Wang J et al. Genotype distribution and prevalence of human papillomavirus among women with cervical cytological abnormalities in Xinjiang, China. Hum Vaccin Immunother 2019; 15 (7–8): 1889–96.
- Harari A, Chen Z, Robert D Burk. Human papillomavirus genomics: past, present and future. Curr Probl Dermatol 2014; 45: 1–18.
- Yang Z, Cuzick J, Hunt WC, Wheeler CM. Concurrence of multiple human papillomavirus infections in a large US population-based cohort. Am J Epidemiol 2014; 180 (11): 1066–75.
- Sanjose S, Quint WG, Alemany L et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010; 11 (11): 1048–56.
- Schiffman M, Vaughan LM, Raine-Bennett TR et al. A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results. Gynecol Oncol 2015; 138: 573–8.
Supplementary files
